How much funding has Sensorion raised?

Sensorion has raised $90.0M in total funding, most recently a Venture Round.

Who are Sensorion's investors?

Sensorion's investors include Sanofi Ventures, Redmile Group, Invus, Sofinnova Partners, Artal Asia.

Where is Sensorion headquartered?

Sensorion is headquartered in Montpellier, France.

What industry is Sensorion in?

Sensorion operates in Biotech, Healthcare.

Sensorion

Montpellier, France · Founded 2009 · $90.0M raised

Biotech

Healthcare

Headquarters: Montpellier
Employees: 11–50
Founded: 2009
Business Model: B2B

Website: sensorion.com
Total Funding: $90.0M
Last Round: $72.0M Venture RoundNov 2024
Rounds: 2

About

Sensorion is a French biopharmaceutical company focused exclusively on developing innovative therapies for inner ear disorders, particularly hereditary hearing loss. Founded in 2009 and based in Montpellier, France, the company advances gene therapy programs targeting genetic causes of deafness, including its lead program SENS-601 for GJB2-related hearing loss. Sensorion partners with major hearing health companies such as Sonova to research the genetics of hearing loss, with the goal of providing long-term improvements for patients living with or at risk of debilitating inner ear conditions.

Summary

Sensorion is a Biotech company based in Montpellier, France, founded in 2009. It has raised $90.0M in total across 2 rounds, most recently a $72.0M Venture Round round in Nov 2024. Investors include Sanofi Ventures, Redmile Group and Invus.